drugset

drugset / Trial / NCT00893516

CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma

NCT00893516 ↗

Phase 2 Terminated 5 enrolled Emergent BioSolutions

RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.

Timeline

Start: 2007-05
Primary completion: 2008-10
Completion: 2008-12

Outcome

Outcome not reported

Stopped (Business): “Portfolio consolidation.”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Zanolimumab	Monoclonal antibody	—	—

Indications